Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Dermatologic 1

Conditions

Melanoma 1Advanced Malignant Solid Neoplasm 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 251Magnetic Resonance Spectroscopy 246Cyclophosphamide 240Cisplatin 214Paclitaxel 205Radiotherapy 196Biopsy 172Gemcitabine 155Dexamethasone 150durvalumab 144atezolizumab 125Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 113Radiation 110Pemetrexed 101Etoposide 101Docetaxel 101fludarabine 97venetoclax 95Capecitabine 92Fluorouracil 91Radiosurgery 90Prednisone 89Oxaliplatin 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × dinaciclib × 1 year × Clear all
NCT00937937 2026-05-29

Dinaciclib in Treating Patients With Stage IV Melanoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
72 enrolled 14 charts
Dermatologic

Melanoma

NCT01434316 2026-04-13

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting
121 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡